AstraZeneca Sues FDA Over Generic Seroquel Labels
AstraZeneca PLC has moved to overturn the U.S. Food and Drug Administration's recent refusal to delay the launch of generic versions of the drugmaker's blockbuster anti-psychotic drug Seroquel with labels that...To view the full article, register now.
Already a subscriber? Click here to view full article